Aktis Oncology logo

Aktis Oncology Share Price (NASDAQ: AKTS)

$18.88

-0.69

(-3.53%)

Last updated on

Check the interactive Aktis Oncology Stock chart to analyse performance

Aktis Oncology Key Stats

Check Aktis Oncology key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$19.57
Today's High
$19.84
Today's Low
$18.85
Market Capitalization
$1.1B
Revenue TTM
$5.6M
EBITDA
$-70.9M
Earnings Per Share (EPS)
$-1.16
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-26.5%

Stock Returns calculator for Aktis Oncology Stock including INR - Dollar returns

The Aktis Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aktis Oncology investment value today

Current value as on today

₹1,00,000

Returns

₹0

(0%)

Returns from Aktis Oncology Stock

₹0 (0%)

Dollar Returns*

₹0 (0%)

Indian investors sentiment towards Aktis Oncology Stock

0%

Period: Jan 7, 2026 to Feb 6, 2026. Change in 30 Days versus previous period

Search interest for Aktis Oncology Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Aktis Oncology

  • Name

    Holdings %

  • Vanguard Group Inc

    2.09%

  • Taylor Frigon Capital Management LLC

    1.66%

  • Silverback Aset Management LLC

    1.64%

  • Citadel Advisors Llc

    1.36%

  • RIMA MANAGEMENT, LLC

    0.97%

  • BlackRock Inc

    0.80%

Analyst Recommendation on Aktis Oncology Stock

Rating
Trend

Buy

    72%Buy

    27%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Aktis Oncology(by analysts ranked 0 to 5 stars)

Aktis Oncology Share Price Target

What analysts predicted

Downside of 96.03%

Target:

$0.75

Current:

$18.88

Aktis Oncology share price target is $0.75, a slight Downside of 96.03% compared to current price of $18.88 as per analysts' prediction.

Aktis Oncology Stock Insights

  • Price Movement

    In the last 1 month, AKTS stock has moved up by 50921.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 9.02M → 933.0K (in $), with an average decrease of 89.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -6.42M → -12.05M (in $), with an average decrease of 87.8% per quarter

Aktis Oncology Technicals Summary

Sell

Neutral

Buy

Aktis Oncology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Aktis Oncology Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aktis Oncology logo
-15.27%
-15.27%
-15.27%
309.94%
103.65%
Regeneron Pharmaceuticals, Inc. logo
-1.94%
43.88%
10.64%
4.78%
58.72%
Beone Medicines Ltd logo
10.47%
22.15%
58.35%
41.59%
-4.1%
Vertex Pharmaceuticals Incorporated logo
1.75%
27.63%
1.83%
62.93%
122.94%
Alnylam Pharmaceuticals, Inc. logo
-17.84%
-24.56%
18.82%
50.7%
98.7%

About Aktis Oncology

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.
Organization
Aktis Oncology
Employees
145
CEO
Dr. Matthew Roden Ph.D.
Industry
Electronic Technology

Key Management of Aktis Oncology

NameTitle
Mr. Todd Foley M.B.A.
Co-Founder & Chairman
Dr. Matthew Roden Ph.D.
President, CEO & Director
Dr. Paul L. Feldman Ph.D.
Chief Scientific Officer
Dr. Akos Czibere M.D., Ph.D.
Chief Medical Officer
Dr. Patrick A. Baeuerle Ph.D.
Co-Founder & Member of Scientific Advisory Board
Mr. Kyle D. Kuvalanka
Chief Financial Officer
Dr. Shulamit Ron-Bigger Ph.D.
Chief Operating Officer
Dr. Tyler Benedum Ph.D.
Chief Technical Officer
Mr. Carlos Rodriguez
Executive Director of Corporate Development
Dr. Dasa Lipovsek Ph.D.
VP & Head of Lead Discovery

Important FAQs about investing in AKTS Stock from India :

What is Aktis Oncology share price today?

Aktis Oncology share price today is $18.88 as on at the close of the market. Aktis Oncology share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Aktis Oncology share?

Aktis Oncology share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Aktis Oncology stock price today i.e. is closed at $18.88, lower by 0% versus the 52 week high.

How to invest in Aktis Oncology Stock (AKTS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aktis Oncology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aktis Oncology Shares that will get you 0.0794 shares as per Aktis Oncology share price of $18.88 per share as on February 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Aktis Oncology Stock (AKTS) from India?

Indian investors can start investing in Aktis Oncology (AKTS) shares with as little as ₹90.7125 or $1 (as of February 07, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹907.13 in Aktis Oncology stock (as per the Rupee-Dollar exchange rate as on February 07, 2026). Based on Aktis Oncology share’s latest price of $18.88 as on February 7, 2026 at 2:29 am IST, you will get 0.5297 shares of Aktis Oncology. Learn more about fractional shares .

What are the returns that Aktis Oncology has given to Indian investors in the last 5 years?

Aktis Oncology stock has given 103.65% share price returns and 24.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?